Jacqueline Kraveka to Immunologic Factors
This is a "connection" page, showing publications Jacqueline Kraveka has written about Immunologic Factors.
Connection Strength
0.193
-
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma. Cancer Rep (Hoboken). 2022 Nov; 5(11):e1616.
Score: 0.193